![Poul Strange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Poul Strange worked as a Chief Medical Advisor-Metabolic at PhaseBio Pharmaceuticals, Inc. and as a Principal at Aventis, Inc. and Sanofi-Aventis Ltd.
| Unternehmen | Position | Ende |
|---|---|---|
Sanofi-Aventis Ltd.
 Sanofi-Aventis Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Corporate Officer/Principal | - |
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Corporate Officer/Principal | - |
| PHASEBIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Sanofi-Aventis Ltd.
Sanofi-Aventis Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
